Literature DB >> 14747204

Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients.

Seiko Matsunaga-Irie1, Taro Maruyama, Yukihiro Yamamoto, Yoshiko Motohashi, Hiroshi Hirose, Akira Shimada, Mitsuru Murata, Takao Saruta.   

Abstract

OBJECTIVE: The development of diabetic nephropathy is considered to be associated with oxidative stress. NADPH oxidase and the receptor for advanced glycation end products (RAGE) have attracted attention as mechanisms of generating oxidative stress. We studied the relation between the genotypes of the NADPH p22phox C242T and RAGE G1704T polymorphisms and the development of diabetic nephropathy in type 2 diabetic patients. RESEARCH DESIGN AND METHODS: Using a retrospective review of clinical data, we allocated 181 Japanese type 2 diabetic patients to one of two groups: patients without diabetic nephropathy (group N; n = 108) and patients developing diabetic nephropathy (group D; n = 73) for 10 years or more. The p22phox C242T and RAGE G1704T polymorphisms were examined by Taqman PCR methods.
RESULTS: The frequency of the p22phox CC genotype was significantly higher in group D than in group N (90 vs. 79%; P = 0.0427). The frequency of the RAGE GT + TT genotype was significantly higher in group D than in group N (26 vs. 13%; P = 0.0313). The frequency of the combination of p22phox CC and RAGE GT + TT genotypes was significantly higher in group D than in group N (22 vs. 8%; P = 0.0057). In multiple logistic regression analysis, systolic blood pressure, HbA(1c), triglycerides, and the combination of polymorphisms were shown to be independent variables.
CONCLUSIONS: These results suggest that assessment of the combination of NADPH p22phox C242T and RAGE G1704T polymorphisms may be useful in identifying the risk for developing diabetic nephropathy in type 2 diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747204     DOI: 10.2337/diacare.27.2.303

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  10 in total

1.  Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma.

Authors:  Qing Lan; Tongzhang Zheng; Min Shen; Yawei Zhang; Sophia S Wang; Shelia H Zahm; Theodore R Holford; Brian Leaderer; Peter Boyle; Stephen Chanock
Journal:  Hum Genet       Date:  2006-12-06       Impact factor: 4.132

2.  Glycated albumin activates NADPH oxidase in rat mesangial cells through up-regulation of p47phox.

Authors:  Yanzhang Li; Shuxia Wang
Journal:  Biochem Biophys Res Commun       Date:  2010-04-23       Impact factor: 3.575

3.  Haplotype analysis of NAD(P)H oxidase p22 phox polymorphisms in end-stage renal disease.

Authors:  Kent Doi; Eisei Noiri; Akihide Nakao; Toshiro Fujita; Shuzo Kobayashi; Katsushi Tokunaga
Journal:  J Hum Genet       Date:  2005-10-08       Impact factor: 3.172

4.  Interaction of Smoking and Lead Exposure among Carriers of Genetic Variants Associated with a Higher Level of Oxidative Stress Indicators.

Authors:  Kuo-Jung Ho; Tzu-Hua Chen; Chen-Cheng Yang; Yao-Chung Chuang; Hung-Yi Chuang
Journal:  Int J Environ Res Public Health       Date:  2021-08-06       Impact factor: 3.390

Review 5.  Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.

Authors:  Shi Fang Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  J Mol Med (Berl)       Date:  2009-02-03       Impact factor: 4.599

6.  Association of 1704G/T and G82S polymorphisms in the receptor for advanced glycation end products gene with diabetic retinopathy in Chinese population.

Authors:  H M Zhang; L L Chen; L Wang; Y F Liao; Z H Wu; F Ye; S Xu; L L Yi
Journal:  J Endocrinol Invest       Date:  2009-03       Impact factor: 4.256

7.  Relationship of the p22phox (CYBA) gene polymorphism C242T with risk of coronary artery disease: a meta-analysis.

Authors:  Zhijun Wu; Yuqing Lou; Wei Jin; Yan Liu; Lin Lu; Qiujing Chen; Yucai Xie; Guoping Lu
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

8.  Association of the NAD(P)H oxidase p22 phox gene C242T polymorphism with type 2 diabetes mellitus, diabetic nephropathy, and carotid atherosclerosis with type 2 diabetes mellitus: A meta-analysis.

Authors:  Tao Li; Hai-Feng Xi; Hong-Min Luo; Wen-Xuan Liu; Xia Gao; Dian-Wu Liu; Lei Yang
Journal:  Meta Gene       Date:  2015-08-25

9.  C-Reactive Protein, Advanced Glycation End Products, and Their Receptor in Type 2 Diabetic, Elderly Patients with Mild Cognitive Impairment.

Authors:  Malgorzata Gorska-Ciebiada; Malgorzata Saryusz-Wolska; Anna Borkowska; Maciej Ciebiada; Jerzy Loba
Journal:  Front Aging Neurosci       Date:  2015-10-29       Impact factor: 5.750

10.  Association of the receptor for advanced glycation end-products (RAGE) gene polymorphisms in Malaysian patients with chronic kidney disease.

Authors:  Foo Nian Wong; Kek Heng Chua; Umah Rani Kuppusamy; Chew Ming Wong; Soo Kun Lim; Jin Ai Mary Anne Tan
Journal:  PeerJ       Date:  2016-04-18       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.